Table 5.
n = 588 | |||
---|---|---|---|
Clinical outcome following initial therapy | Low (n = 136) | Intermediate (n = 291) | High (n = 161) |
No evidence of disease | 86% | 57% | 14% |
(n = 305) | (117) | (166) | (22) |
Persistent disease, biochemical evidence | 11% | 22% | 18% |
(n = 108) | (15) | (64) | (29) |
Persistent disease, structurally identifiable | 2% | 19% | 67% |
(n = 167) | (3) | (56) | (108) |
Recurrent disease | 1% | 2% | 1% |
(n = 8) | (1) | (5) | (2) |